Stellate Therapeutics

Biotechnology ResearchNew York, United States2-10 Employees

Stellate Therapeutics is a pre-clinical stage start-up company developing innovative microbiome-derived small molecules to treat neurodegenerative diseases.  We utilize the microbiome for our drug portfolio and our research focuses on the gut-brain axis.  Due to millions of years of co-evolution, complex metabolic interactions exist between humans and their gut bacteria and Stellate has uncovered a unique set of metabolites that are produced by the microbiome and are involved in the maintenance of health.  Our first drug will be a treatment for Parkinson’s disease.

Sign up for free to view info

Email Format Employee directory